RT Journal Article
SR Electronic
T1 Preliminary Rasch analysis of the Multidimensional Assessment of Interoceptive Awareness in adults with stroke
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2022.03.09.22272162
DO 10.1101/2022.03.09.22272162
A1 Jena Blackwood
A1 Sydney Carpentier
A1 Wei Deng
A1 Ann Van de Winckel
YR 2022
UL http://medrxiv.org/content/early/2022/04/19/2022.03.09.22272162.abstract
AB Purpose The Multidimensional Assessment of Interoceptive Awareness (MAIA) measures interoceptive body awareness, which includes aspects such as attention regulation, self-regulation, and body listening. Our purpose was to validate the MAIA in adults with stroke using Rasch Measurement Theory.Methods The original MAIA has 32 items grouped into 8 separately scored subscales that measure aspects of body awareness. Using Rasch Measurement Theory we evaluated the unidimensionality of the entire scale and investigated person and item fit, person separation reliability, targeting, local item dependence, and principal components analysis of residuals.Results Forty-one adults with chronic stroke (average 3.8 years post-stroke, 13 women, average age 57±13 years) participated in the study. Overall fit (χ2=62.26, p=0.26) and item fit were obtained after deleting 3 items and rescoring 26 items. One participant did not fit the model (2.44%). There were no floor (0.00%) or ceiling effects (0.00%). Local item dependence was found in 42 pairs. The person separation reliability was 0.91, and the person mean location was 0.06±1.12 logits.Conclusions The MAIA demonstrated good targeting and reliability, as well as good item and person fit in adults with chronic stroke. A study with a larger sample size is needed to validate our findings.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialNCT03328468Funding StatementThis work was supported by the National Center for Advancing Translational Sciences of the National Institutes of Health Award Number UL1TR000114. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health National Center for Advancing Translational Sciences. The funders have no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study was approved by the University of Minnesota Internal Review Board (IRB number STUDY00000821).I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe dataset supporting the conclusions of this article is available in the Data Repository for U of M (DRUM). https://doi.org/10.13020/pgc5-6659